Categories: The Charlton Centre

Are You Ready to Quit?

Autoimmune diseases are more common and may also progress at a greater rate amongst those who smoke tobacco. Treatments such as biologics don’t work as well in people who continue to smoke. At Charlton Health we are happy to assist people in quitting smoking.

Heart disease is greater in those who smoke and in conditions with high inflammation, heart disease is also higher than in the general public. Many of the conditions we treat also have potential lung complications, and of course smoking increases lung damage.

For all these reasons, quitting smoking is the best thing a person can do for their health, and even more so for people with the conditions listed above.

This week, as National Non-Smoking Week, is a good time to think about quitting. If you need assistance or strategies, or a better understanding of the treatment options available, please reach out to us. We look forward to working with you.

Learn more about National Non-Smoking Week here.


Carolyn Whiskin is the Pharmacy Manager for Charlton Health.  Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 days ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

3 weeks ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 month ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

2 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago